NDC 68083-412 – Cangrelor

Cangrelor 50 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC68083-412

Product details

Brand name
Cangrelor
Generic name
Cangrelor
Labeler
Gland Pharma Limited
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
ANDA · ANDA213551
Marketed since
August 11, 2025
Listing expires
December 31, 2026
Pharmacologic class
P2Y12 Platelet Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Cangrelor →

Package NDC codes (1)

Package NDCDescriptionSince
68083-412-1010 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSEAug 11, 2025